Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Dow
Johnson and Johnson
Merck
Boehringer Ingelheim
Express Scripts
Moodys

Last Updated: October 20, 2019

DrugPatentWatch Database Preview

Wyeth Ayerst Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for WYETH AYERST, and what generic and branded alternatives to WYETH AYERST drugs are available?

WYETH AYERST has eighty-two approved drugs.



Summary for Wyeth Ayerst
US Patents:0
Tradenames:64
Ingredients:56
NDAs:82

Drugs and US Patents for Wyeth Ayerst

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Ayerst EQUANIL meprobamate TABLET;ORAL 010028-004 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Wyeth Ayerst PATHOCIL dicloxacillin sodium CAPSULE;ORAL 050011-003 Mar 28, 1983 DISCN No No   Start Trial   Start Trial
Wyeth Ayerst UNIPEN nafcillin sodium INJECTABLE;INJECTION 062717-001 Dec 16, 1986 DISCN No No   Start Trial   Start Trial
Wyeth Ayerst SPARINE promazine hydrochloride SYRUP;ORAL 010942-003 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Wyeth Ayerst CEFPIRAMIDE SODIUM cefpiramide sodium INJECTABLE;INJECTION 050633-005 Jan 31, 1989 DISCN No No   Start Trial   Start Trial
Wyeth Ayerst SECOBARBITAL SODIUM secobarbital sodium INJECTABLE;INJECTION 083262-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Wyeth Ayerst

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Ayerst ORUDIS ketoprofen CAPSULE;ORAL 018754-002 Jan 9, 1986 3,641,127   Start Trial
Wyeth Ayerst WYTENSIN guanabenz acetate TABLET;ORAL 018587-003 Sep 7, 1982 3,658,993   Start Trial
Wyeth Ayerst WYTENSIN guanabenz acetate TABLET;ORAL 018587-001 Sep 7, 1982 3,658,993   Start Trial
Wyeth Ayerst INDERIDE LA 120/50 hydrochlorothiazide; propranolol hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 019059-002 Jul 3, 1985 4,138,475   Start Trial
Wyeth Ayerst INDERAL propranolol hydrochloride SUSPENSION;ORAL 019536-001 Dec 12, 1986 4,600,708   Start Trial
Wyeth Ayerst WYTENSIN guanabenz acetate TABLET;ORAL 018587-002 Sep 7, 1982 3,658,993   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Boehringer Ingelheim
AstraZeneca
Mallinckrodt
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.